Pulminiq FDA Approval Status

FDA Approved: No
Brand name: Pulminiq
Generic name: cyclosporine
Dosage form: Inhalation Solution
Company: Chiron Corporation
Treatment for: Organ Transplant, Rejection Prophylaxis

Development timeline for Pulminiq

Date	Article
Jul 15, 2005	FDA Requests Additional Data on Pulminiq (Cyclosporine, USP) Inhalation Solution; Agency Action Letter States that Pulminiq is ''Approvable'' But Additional Study is Required
Dec 15, 2004	Chiron Receives FDA Priority Review Designation for New Drug Application for Pulminiq -- Cyclosporine, USP-- Inhalation Solution
Oct 14, 2004	Chiron Submits New Drug Application for Pulminiq; Inhaled Form of Cyclosporine Could Be First Immunosuppressant Indicated for Chronic Lung-Transplant Rejection

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer